Text Size

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Hannover Medical School.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
University of Ulm
Klinikum der J.W. Goethe Universitaet
University Hospital Freiburg
Zentralklinikum, Augsburg
Humboldt-Universität zu Berlin
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Ghent
Medizinische Universitätsklinik Tübingen
Klinikum Hanover-Siloah Hospital
Ev. Krankenhaus Essen-Werden
Klinikum Wuppertal GmbH
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT00209833
First received: September 13, 2005
Last updated: November 17, 2005
Last verified: September 2005
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
No publications provided by Hannover Medical School

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):